Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: A combined radionuclide-hemodynamic study
Authors:
- Bruce N. BrentBBBruce N. Brent
- Harvey J. BergerHBHarvey J. Berger
- Richard A. MatthayRMRichard A. Matthay
- Donald MahlerDMDonald Mahler
- Linda PytlikLPLinda Pytlik
- Barry L. ZaretBZBarry L. Zaret
- 1 June 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (10) , 1682-1689
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Physiologic correlates of right ventricular ejection fraction in chronic obstructive pulmonary disease: A combined radionuclide and hemodynamic studyThe American Journal of Cardiology, 1982
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.Circulation, 1982
- Inhibition of Hypoxic Pulmonary Vasoconstriction by NifedipineNew England Journal of Medicine, 1981
- Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonaleThe American Journal of Cardiology, 1981
- Nitroglycerin and Long-Acting NitratesNew England Journal of Medicine, 1980
- Diazoxide in Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Oral Hydralazine Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1980
- Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertensionThe American Journal of Cardiology, 1978
- Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion.Circulation, 1977